Correlation between peritoneal mesothelial cell cytology and peritoneal histopathology with respect to prognosis in patients on continuous ambulatory peritoneal dialysis

Nephron

Volumn 89, Issue 1, 2001, Pages 43-49

  Izumotani, Tsuyoshi ^a   Ishimura, Eiji ^b   Yamamoto, Tadashi ^a   Otoshi, Tatsuyuki ^a   Okuno, Senji ^a   Inaba, Masaaki ^b   Kim, Masao ^a   Nishizawa, Yoshiki ^b  

^a Shirasagi Hospital   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Continuous ambulatory peritoneal dialysis; Effluent dialysate; Mesothelial cell; Peritoneal histopathology; Peritoneal sclerosis; Sclerosing encapsulating peritonitis

Indexed keywords

ADULT; AGED; ARTICLE; BIOPSY; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CORRELATION FUNCTION; CYTOLOGY; DIALYSATE; EFFLUENT; FEMALE; FIBROSIS; GIANT CELL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MESOTHELIUM CELL; OUTCOMES RESEARCH; PERITONEUM CELL; PERITONITIS; PRIORITY JOURNAL; PROGNOSIS; SCLEROSIS;

ADULT; AGED; CREATININE; DIALYSIS SOLUTIONS; EPITHELIUM; FEMALE; GIANT CELLS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PERITONEUM; PERITONITIS; PROGNOSIS; SCLEROSIS;

EID: 0034866738     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000046042     Document Type: Article

References (19)

1. Morphological studies of mesothelial cells in CAPD effluent and their clinical significance
2. Peritoneal morphology on maintenance dialysis
3. Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis
4. The peritoneal fibroblast and the control of peritoneal inflammation
5. Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis
6. Sclerosing encapsulating peritonitis (SEP) in patients on continuous ambulatory peritoneal dialysis - Definition, diagnosis and treatment recommendations, 1997 update
7. Sclerosing peritonitis: The experience in Australia
8. Sclerosing encapsulating peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: A report of the Japanese sclerosing encapsulating peritonitis study group
9. Peritoneal sclerosis in chronic peritoneal dialysis patients: Analysis of clinical presentation, risk factors and peritoneal transport kinetics
10. Cell populations present in the nocturnal peritoneal effluent of patients on continuous ambulatory peritoneal dialysis and their relationship with peritoneal function and incidence of peritonitis
11. The fast peritoneal equilibration test
12. Radiological view of sclerosing peritonitis
13. Case control study to determine the cause of sclerosing peritoneal disease
14. Present status of CAPD in Japan
15. Sclerosing peritonitis complicating prolonged use of chlorhexidine in alcohol in the connection procedure for continuous ambulatory peritoneal dialysis
16. Transformed mesothelial cells in patients on CAPD for medium- to long-term periods
17. New concepts in molecular biology and ultrastructural pathology of the peritoneum: Their significance for peritoneal dialysis
18. Peritoneal dialysis solution induces apoptosis of mesothelial cells
19. Does impaired transcellular water transport contribute to net ultrafiltration failure during CAPD?